Catalent Revenue 2012-2020 | CTLT

Catalent annual/quarterly revenue history and growth rate from 2012 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Catalent revenue for the quarter ending March 31, 2020 was $0.761B, a 23.17% increase year-over-year.
  • Catalent revenue for the twelve months ending March 31, 2020 was $2.872B, a 15.93% increase year-over-year.
  • Catalent annual revenue for 2019 was $2.518B, a 2.22% increase from 2018.
  • Catalent annual revenue for 2018 was $2.463B, a 18.7% increase from 2017.
  • Catalent annual revenue for 2017 was $2.075B, a 12.3% increase from 2016.
Catalent Annual Revenue
(Millions of US $)
2019 $2,518
2018 $2,463
2017 $2,075
2016 $1,848
2015 $1,831
2014 $1,828
2013 $1,800
2012 $1,695
2011 $1,532
Catalent Quarterly Revenue
(Millions of US $)
2020-03-31 $761
2019-12-31 $721
2019-09-30 $665
2019-06-30 $726
2019-03-31 $618
2018-12-31 $623
2018-09-30 $552
2018-06-30 $685
2018-03-31 $628
2017-12-31 $606
2017-09-30 $544
2017-06-30 $617
2017-03-31 $533
2016-12-31 $484
2016-09-30 $442
2016-06-30 $532
2016-03-31 $438
2015-12-31 $455
2015-09-30 $423
2015-06-30 $510
2015-03-31 $447
2014-12-31 $456
2014-09-30 $418
2014-06-30 $520
2014-03-31 $453
2013-12-31 $441
2013-09-30 $414
2013-06-30
2013-03-31
2012-06-30
2011-06-30
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.600B $2.518B
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. Catalent, Inc. is headquartered in Somerset, New Jersey.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.719B 43.07
Takeda Pharmaceutical (TAK) Japan $58.925B 10.27
Astellas Pharma (ALPMY) Japan $30.273B 15.34
Eisai (ESALY) Japan $25.840B 21.84
UCB SA (UCBJF) Belgium $23.720B 0.00
Merck (MKGAF) Germany $17.131B 22.47
Grifols, S.A (GRFS) Spain $12.582B 15.38
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $10.650B 41.23
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $7.401B 46.88
Orion OYJ (ORINY) Finland $7.077B 24.56
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.052B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.663B 11.02
United Therapeutics (UTHR) United States $4.908B 11.35
Arrowhead Pharmaceuticals (ARWR) United States $4.379B 0.00
Evotec AG (EVTCY) Germany $4.113B 142.92
FibroGen (FGEN) United States $4.075B 0.00
Hypermarcas (HYPMY) Brazil $3.895B 14.33
ChemoCentryx (CCXI) United States $3.651B 0.00
Nektar Therapeutics (NKTR) United States $3.596B 0.00
PTC Therapeutics (PTCT) United States $3.214B 0.00
Pacira BioSciences (PCRX) United States $2.617B 68.79
Sage Therapeutics (SAGE) United States $2.606B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.454B 11.88
Cronos Group (CRON) Canada $2.026B 0.00
Xencor (XNCR) United States $1.862B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.787B 0.00
USANA Health Sciences (USNA) United States $1.762B 16.60
Revolution Medicines (RVMD) United States $1.721B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.615B 11.26
Indivior (INVVY) United States $1.573B 19.49
Corcept Therapeutics (CORT) United States $1.554B 14.31
Akebia Therapeutics (AKBA) United States $1.505B 0.00
Heron Therapeutics (HRTX) United States $1.431B 0.00
Zogenix (ZGNX) United States $1.373B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.258B 12.00
CLINIGEN GP (CLIGF) United Kingdom $1.102B 0.00
Karyopharm Therapeutics (KPTI) United States $1.091B 0.00
Translate Bio (TBIO) United States $1.075B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.068B 0.00
VAXART, INC (VXRT) United States $1.005B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.966B 601.63
Esperion Therapeutics (ESPR) United States $0.937B 0.00
Tilray (TLRY) Canada $0.862B 0.00
Altimmune (ALT) United States $0.743B 0.00
Endo (ENDP) Ireland $0.742B 1.10
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
Trillium Therapeutics (TRIL) Canada $0.705B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.701B 0.00
ImmunoGen (IMGN) United States $0.674B 0.00
Collegium Pharmaceutical (COLL) United States $0.630B 0.00
Flexion Therapeutics (FLXN) United States $0.614B 0.00
Molecular Templates (MTEM) United States $0.600B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.581B 0.00
Aerie Pharmaceuticals (AERI) United States $0.577B 0.00
Siga Technologies (SIGA) United States $0.566B 60.33
Radius Health (RDUS) United States $0.564B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.536B 0.00
Ocular Therapeutix (OCUL) United States $0.519B 0.00
Ardelyx (ARDX) United States $0.511B 0.00
Innate Pharma SA (IPHYF) France $0.506B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.504B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.474B 23.66
DURECT (DRRX) United States $0.463B 0.00
TherapeuticsMD (TXMD) United States $0.433B 0.00
Organogenesis Holdings (ORGO) United States $0.429B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.422B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.348B 8.62
Harpoon Therapeutics (HARP) United States $0.326B 0.00
Redhill Biopharma (RDHL) Israel $0.324B 0.00
MEI Pharma (MEIP) United States $0.318B 0.00
OptiNose (OPTN) United States $0.304B 0.00
IMV INC (IMV) Canada $0.297B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.290B 0.00
Calithera Biosciences (CALA) United States $0.290B 0.00
Concert Pharmaceuticals (CNCE) United States $0.288B 0.00
PROFOUND MEDICL (PROF) Canada $0.286B 0.00
Rafael Holdings (RFL) United States $0.286B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.269B 0.00
Heat Biologics (HTBX) United States $0.266B 0.00
Lannett Co Inc (LCI) United States $0.240B 5.27
CASI Pharmaceuticals (CASI) United States $0.238B 0.00
KalVista Pharmaceuticals (KALV) United States $0.228B 0.00
Nivalis Therapeutics (ALPN) United States $0.219B 0.00
Nature's Sunshine Products (NATR) United States $0.217B 21.39
Aquestive Therapeutics (AQST) United States $0.216B 0.00
Taiwan Liposome (TLC) Taiwan $0.192B 0.00
Onconova Therapeutics (ONTX) United States $0.179B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.171B 0.00
Jounce Therapeutics (JNCE) United States $0.161B 7.63
Xeris Pharmaceuticals (XERS) United States $0.148B 0.00
Champions Oncology (CSBR) United States $0.120B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.118B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.112B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Biomerica (BMRA) United States $0.107B 0.00
India Globalization Capital (IGC) United States $0.105B 0.00
Otonomy (OTIC) United States $0.102B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.100B 0.00
Hemispherx BioPharma (AIM) United States $0.100B 0.00
Lipocine (LPCN) United States $0.099B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.097B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.095B 0.00
Aclaris Therapeutics (ACRS) United States $0.094B 0.00
MediWound (MDWD) Israel $0.090B 0.00
CTI BioPharma (CTIC) United States $0.089B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.088B 0.00
Addex Therapeutics (ADXN) Switzerland $0.077B 0.00
ElectroCore (ECOR) United States $0.075B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
Recro Pharma (REPH) United States $0.072B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.071B 0.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
CV Sciences (CVSI) United States $0.065B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.063B 0.00
Sundial Growers (SNDL) Canada $0.058B 0.00
GTx (ONCT) United States $0.058B 0.00
PolarityTE (PTE) United States $0.056B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.053B 31.64
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Natural Alternatives (NAII) United States $0.048B 0.00
IsoRay (ISR) United States $0.046B 0.00
Novan (NOVN) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
AgeX Therapeutics (AGE) United States $0.043B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 0.00
Jaguar Animal Health (JAGX) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.036B 9.09
Bellicum Pharmaceuticals (BLCM) United States $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Neos Therapeutics (NEOS) United States $0.033B 0.00
ProPhase Labs (PRPH) United States $0.033B 0.00
Can-Fite Biopharma (CANF) Israel $0.033B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.028B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
Vical (BBI) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
RXi Pharmaceuticals (PHIO) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 21.18
Shineco (TYHT) China $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.013B 0.00
Midatech Pharma (MTP) United Kingdom $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00